Nasdaq

BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease

First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PAD FRANKLIN LAKES, N.J., March 4, 2024 /PRNewswire/ -- BD ...

Study splits schizophrenia genetic risk into two pathways, one shared with bipolar disorder

A new study by researchers at King's College London has split schizophrenia risk into two genetically distinct pathways. One is characterized by a shared genetic risk with bipolar disorder and ...
Morningstar

BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease

FRANKLIN LAKES, N.J., Nov. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient ...
New Atlas

Keto diet improves bipolar disorder symptoms in new study

People with bipolar disorder who followed a ketogenic diet for at least six weeks found that their symptoms improved, a new study has found. While the study was small and preliminary, its findings ...
Nasdaq

BD's (BDX) ADC System Favored by New Study for Long-Term Care

Becton, Dickinson and Company BDX, popularly known as BD, recently announced positive new data from a research study assessing the impact of deploying automated dispensing cabinets (ADCs) in long-term ...